MRK Merck & Co., Inc.
Healthcare$119.76-2.16%ClosedMarket Cap: $295.79B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$129.31
Target (Median)
$133.00
Target Range
$100.00 - $150.00
Upside from current price: 8.0%
Rating Distribution
4 Strong Buy15 Buy10 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-01 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-04-13 | UBS | maintain | Buy | Buy |
| 2026-04-06 | JP Morgan | maintain | Overweight | Overweight |
| 2026-03-30 | RBC Capital | maintain | Outperform | Outperform |
| 2026-03-20 | Citigroup | maintain | Neutral | Neutral |
| 2026-03-12 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-09 | Freedom Broker | maintain | Hold | Hold |
| 2026-02-06 | Guggenheim | maintain | Buy | Buy |
| 2026-02-04 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-02-04 | Cantor Fitzgerald | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $9.64 | $70.16B | 5 |
| Sun Dec 31 | $10.68 | $74.90B | 3 |
| Mon Dec 31 | $10.36 | $74.94B | 1 |
| Tue Dec 31 | $9.99 | $74.24B | 1 |